Pathway Health Corp. PHC KL (formerly Colson Capital Corp.) has signed a collaboration agreement with Sunshine Drugs, a family of 15 community based pharmacies located primarily in Southwest Ontario. The agreement details the implementation of Pathway's Medical Cannabis Management System ("MCMS") in a planned November, 2022 rollout.
The joint initiative has two components, the first consisting of Pathway providing its accredited continuing education course "Cannabis and Patient Care for Pharmacists" which trains pharmacists in patient assessments and current prescription reviews for patient suitability. The course meets or exceeds the requirements of the Canadian Council on Continuing Education in Pharmacy and the Ontario College of Pharmacists as well as being approved for all other Provinces and in a bi-lingual format. The second initiative involves the implementation of Pathway's MCMS in various Sunshine Pharmacy locations in Canada.
Pathway's MCMS was designed to be implemented in retail pharmacies, with the overarching goals of providing access points for medical cannabis care and enabling pharmacists to offer medical cannabis assessments to appropriate pharmacy patients. Under the MCMS, patients are then connected to their own General Practitioner or a Pathway physician/nurse practitioner for further evaluation through either physical or telemedicine care. The MCMS has also been designed to be integrated into a formal medication review for the pharmacist. The MCMS offers patient assessment tools for the pharmacist including consent forms, marketing material, back-end patient communication, standard operating procedures, and additional continuing education opportunities to over 2,000 pharmacies across Canada.
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
- Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
- Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
- Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
Photo by Tim Foster on Unsplash
Related News
Pathway Health To Acquire IRP Health From Wellbeing Digital Sciences
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
